Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 |Industry: Pharmaceuticals
|Expensive Rocket

Aurobindo Pharma Ltd.    
13 Mar 2019
773.10
0.42%
Angel Broking
Aurobindo Pharmaceuticals (APL) has a big relief in form of Establishment Inspection report (EIR) for Unit-4 facility in which the USFDA has closed issued Form 483. The Form 483 is issued to a firms management at the conclusion of an inspection when an investigator(s) has observed any conditions that may constitute violations of the Food
default
Prabhudas Lilladhar released a Buy report for Aurobindo Pharma Ltd. with a price target of 952.0 on 20 Mar, 2019.
Recommended
More from Aurobindo Pharma Ltd.